ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages

FASEB Journal

Volumn 15, Issue 9, 2001, Pages 1555-1561

  Von Eckardstein, Arnold ^a   Langer, Claus ^a   Engel, Thomas ^a   Schaukal, Isabel ^a   Cignarella, Andrea ^a,b   Reinhardt, Jürgen ^a   Lorkowski, Stefan ^a   Li, Zhengchen ^a   Zhou, Xiaoqin ^a   Cullen, Paul ^a   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ABCA1; ApoE; Tangier disease

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN E; GLIBENCLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; TANGIER DISEASE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MACROPHAGES; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER;

EID: 17844411455     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0798com     Document Type: Article

References (49)

1. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
2. Apolipoprotein E and atherosclerosis
3. A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia
4. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
5. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
6. Apolipoprotein E secretion by macrophages: Its potential functions
7. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice
8. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
9. Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E
10. 3 and lipid-free apolipoproteins in mouse peritoneal macrophages
11. Apolipoprotein E inhibits platelet derived growth factor induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase
12. Cell-derived apolipoprotein E particles inhibit VCAM expression in human endothelial cells
13. Phenotype-dependent differences in apolipoprotein E metabolism and cholesterol homeostasis in human monocyte-derived macrophages
14. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
15. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage like foam cells
16. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages
17. Transport and processing of endogenously synthesized apoE on the macrophage cell surface
18. Interferon gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms
19. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
20. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
21. Monensin and brefeldin A inhibit high density lipoprotein mediated cholesterol efflux from cholesterol-enriched cells. Implications for intracellular cholesterol trafficking
22. Interferon-γ induces downregulation of Tangier disease gene (ATP binding cassette transporter 1) in macrophage-derived foam cells
23. ABC1-mediated transport of cellular cholesterol to HDL and apolipoproteins
24. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease. Patients and Abc1-deficient mice
25. Specific binding of apoA-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1
26. ABCA1 is the cAMP-inducible receptor that mediates cholesterol secretion from macrophages
27. Familial high density lipoprotein deficiency: Tangier disease
28. Molecular Cloning of the human ATP binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
29. ABCG1 (ABC8), the human homolog of the Drosophila white gene is a regulator of macrophage cholesterol and phospholipid transport
30. Identification of cAMP analogue inducible genes in RAW264 macrophages
31. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
32. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters
33. The gene encoding ATP binding cassette transporter 1 is mutated in Tangier disease
34. Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1
35. The Tangier disease gene product controls the cellular apolipoprotein-mediated lipid removal pathway
36. Effects of the Apolipoprotein E-polymorphism on uptake and transfer of cell-derived cholesterol in plasma
37. Cyclic nucleotide analogs as biochemical tools and prospective drugs
38. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes
39. Interleukin 1β secretion is impaired by inhibitors of the ATP binding cassette transporter ABC1
40. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine
41. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
42. Lysosomal degradation and sorting of apolipoprotein E in macrophages
43. Apolipoprotein E in macrophages and hepatocytes is degraded via the proteasomal pathway
44. Tangier disease: A disorder of intracellular membrane traffic
45. Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway
46. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation
47. ABC transporters in cellular lipid trafficking
48. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles
49. Plasma lipoproteins: Apolipoprotein structure and function